» Authors » G Darling

G Darling

Explore the profile of G Darling including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 246
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
4.
Atlas H, Safa N, Denis R, Garneau P, Marceau S, Lebel S, et al.
Can J Surg . 2022 Apr; 53(4):S51-S104. PMID: 35488396
No abstract available.
5.
Bodie G, Hagen J, Almamar A, Majumdar S, Wang X, Tuepah R, et al.
Can J Surg . 2022 Apr; 55(4 Suppl 1):S63-S135. PMID: 35488395
No abstract available.
6.
Droeser R, Kaneva P, Cheng V, Lam L, Benjamin E, Matsushima K, et al.
Can J Surg . 2022 Apr; 61(4 Suppl 1):S94-S174. PMID: 35488393
No abstract available.
7.
Unger B, Gillman L, Hickey K, Pace D, Lam-Tin-Cheung K, Catton J, et al.
Can J Surg . 2022 Apr; 64(6 Suppl 2):S80-S159. PMID: 35483046
No abstract available.
8.
Sun A, Durocher-Allen L, Ellis P, Ung Y, Goffin J, Ramchandar K, et al.
Curr Oncol . 2019 Jul; 26(3):e372-e384. PMID: 31285682
Background: Patients with limited-stage (ls) or extensive-stage (es) small-cell lung cancer (sclc) are commonly given platinum-based chemotherapy as first-line treatment. Standard chemotherapy for patients with ls sclc includes a platinum...
9.
Keech J, Beca J, Eisen A, Kennedy E, Kim J, Kouroukis C, et al.
Curr Oncol . 2019 May; 26(2):e155-e161. PMID: 31043821
Background: In Canada, requests for public reimbursement of cancer drugs are predominately initiated by pharmaceutical manufacturers. Clinician-led submissions provide a mechanism to initiate the drug funding process when industry does...
10.
Natori A, Chan B, Sim H, Ma L, Yokom D, Chen E, et al.
Curr Oncol . 2019 Jan; 25(6):366-370. PMID: 30607110
Background: We aimed to assess current treatment patterns and outcomes in elderly patients with localized gastric and esophageal (ge) cancers. Methods: This retrospective analysis considered patients 75 years of age...